SEC Form SC 13G filed by BrightSpring Health Services Inc.

11/8/24 11:14:20 AM ET

Medical/Nursing Services

Health Care

Get the next $BTSG alert in real time by email

SC 13G 1 efc24-0930_formsc13g.txt UNITED STATES SECURITIES EXCHANGE COMMISSION Washington, D.C. 20549 ------------------------------------------------------------------------------- SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.)* BrightSpring Health Services, Inc. ---------------------------------------------- (Name of Issuer) Preferred Stock ----------------------------------------------------- (Title of Class of Securities) 10950A205 --------------------- (CUSIP Number) September 30, 2024 ---------------- (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Continued on following pages Page 1 of 5 Pages SCHEDULE 13G CUSIP No.: 10950A205 Page 2 of 5 Pages ................................................................................ 1. Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). NORGES BANK (THE CENTRAL BANK OF NORWAY) ................................................................................ 2. Check the Appropriate Box if a Member of a Group (a) [ ] (b) [ ] N/A ................................................................................ 3. SEC Use Only ................................................................................ 4. Citizenship or Place of Organization NORWAY ................................................................................ Number of 5. Sole Voting Power 425,000 Shares Beneficially ................................................................ Owned by Each Reporting 6. Shared Voting Power 0 Person With ................................................................ 7. Sole Dispositive Power 425,000 ................................................................ 8. Shared Dispositive Power 0 ................................................................................ 9. Aggregate Amount Beneficially Owned by Each Reporting Person 425,000 ................................................................................ 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) N/A ................................................................................ 11. Percent of Class Represented by Amount in Row (9) 5.31 % ................................................................................ 12. Type of Reporting Person: OO, FI CUSIP No.: 10950A205 Page 3 of 5 Pages Item 1(a). Name of Issuer: BrightSpring Health Services, Inc. Item 1(b). Address of Issuer's Principal Executive Offices: 805 N. Whittington Parkway, Louisville, Kentucky 40222 Item 2(a). Name of Person Filing: This Statement is filed on behalf of each of the following persons (collectively, the "Reporting Persons"): NORGES BANK (CENTRAL BANK OF NORWAY) Item 2(b). Address of Principal Business Office or, if None, Residence: Bankplassen 2 PO Box 1179 Sentrum NO 0107 Oslo Norway Item 2(c). Citizenship: Norwegian Item 2(d). Title of Class of Securities: Preferred Stock Item 2(e). CUSIP Number: 10950A205 Item 3. If this statement is filed pursuant to rule 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: (a) [ ] Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o); (b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c); (c) [ ] Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c); (d) [ ] Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8); (e) [ ] An investment adviser in accordance with rule 240.13d-1(b)(1)(ii)(E); (f) [ ] An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F); (g) [ ] A parent holding company or control person in accordance with rule 240.13d-1(b)(1)(ii)(G); (h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) [ ] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) [X] A non-U.S. institution in accordance with 240.13d-1(b)(1)(ii)(J); (k) [ ] Group, in accordance with 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with 240.13d-1(b)(1)(ii)(J) please specify the type of institution: investment adviser. CUSIP No.: 10950A205 Page 4 of 5 Pages Item 4(a)-(c)(iv). Ownership: Items 5-11 of the cover pages are incorporated by reference. Item 5. Ownership of Five Percent or Less of a Class: If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class securities, check the following [ ]. Item 6. Ownership of More than Five Percent on Behalf of Another Person: The shares reported herein are invested on behalf of the Government of Norway. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company: This Item 7 is not applicable. Item 8. Identification and Classification of Members of the Group: This Item 8 is not applicable. Item 9. Notice of Dissolution of Group: This Item 9 is not applicable. Item 10. Certification: By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under section 240.14a-11. By signing below I certify that, to the best of my knowledge and belief, the foreign regulatory scheme applicable to the investment management division of Norges Bank, the central bank of Norway, is substantially comparable to the regulatory scheme applicable to the functionally equivalent U.S. institution(s). I also undertake to furnish to the Commission staff, upon request, information that would otherwise be disclosed in a Schedule 13D. CUSIP No.: 10950A205 Page 5 of 5 Pages SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. NORGES BANK Date: November 08,2024 By: /s/ Aya Sobhy ---------------------- Name: Aya Sobhy Title: Regulatory Compliance Advisor

Get the next $BTSG alert in real time by email

Recent Analyst Ratings for

$BTSG

Date	Price Target	Rating	Analyst
6/23/2025	$37.00	Buy	TD Cowen
12/12/2024		Market Outperform	CJS Securities
10/11/2024		Sector Weight	KeyBanc Capital Markets
6/21/2024	$15.00	Buy	BTIG Research
3/6/2024	$13.00	Buy	HSBC Securities
2/27/2024	$11.50	Hold → Buy	Deutsche Bank
2/20/2024	$15.00	Buy	Guggenheim
2/20/2024	$15.00	Outperform	Leerink Partners

More analyst ratings

SEC Form SC 13G filed by BrightSpring Health Services Inc.

11/8/24 11:14:20 AM ET

$BTSG

Medical/Nursing Services

Health Care

Get the next $BTSG alert in real time by email

Recent Analyst Ratings for

$BTSG

Date	Price Target	Rating	Analyst
6/23/2025	$37.00	Buy	TD Cowen
12/12/2024		Market Outperform	CJS Securities
10/11/2024		Sector Weight	KeyBanc Capital Markets
6/21/2024	$15.00	Buy	BTIG Research
3/6/2024	$13.00	Buy	HSBC Securities
2/27/2024	$11.50	Hold → Buy	Deutsche Bank
2/20/2024	$15.00	Buy	Guggenheim
2/20/2024	$15.00	Outperform	Leerink Partners

More analyst ratings

SEC Form SC 13G filed by BrightSpring Health Services Inc.

Crush Q3 2025 with the Best AI Executive Assistant

Recent Analyst Ratings for $BTSG

SEC Form SC 13G filed by BrightSpring Health Services Inc.

Crush Q3 2025 with the Best AI Executive Assistant

Recent Analyst Ratings for $BTSG

$BTSG Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Large owner Kkr Group Partnership L.P. bought $129,330,578 worth of shares (11,619,998 units at $11.13) (SEC Form 4)

Large owner Kkr Phoenix Aggregator L.P. bought $129,330,578 worth of shares (11,619,998 units at $11.13) (SEC Form 4)

Dambrosio Matthew bought $11,461 worth of shares (1,000 units at $11.46) (SEC Form 4)

$BTSG Press Releases

Fastest customizable press release news feed in the world

BrightSpring Health Services, Inc. to Announce Second Quarter 2025 Financial Results on August 1, 2025

BrightSpring Health Services Announces Onco360® Selected as National Pharmacy Partner for Multiple New Cancer and Rare Disease Drugs

BrightSpring Announces Pricing of Secondary Offering of Common Stock

$BTSG Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Officer Rousseau Jon B increased direct ownership by 5% to 1,131,930 units (SEC Form 4)

President, PharMerica Greenwell Scott A. was granted 16,839 shares (SEC Form 4)

SEC Form 3 filed by new insider Greenwell Scott A.

$BTSG Financials

Live finance-specific insights

BrightSpring Health Services, Inc. to Announce Second Quarter 2025 Financial Results on August 1, 2025

BrightSpring Health Services, Inc. to Announce First Quarter 2025 Financial Results on May 2, 2025

BrightSpring Health Services, Inc. to Announce Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025

$BTSG SEC Filings

SEC Form SCHEDULE 13G filed by BrightSpring Health Services Inc.

BrightSpring Health Services Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

BrightSpring Health Services Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

$BTSG Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

TD Cowen initiated coverage on BrightSpring Health Services with a new price target

CJS Securities initiated coverage on BrightSpring Health Services

KeyBanc Capital Markets initiated coverage on BrightSpring Health Services

$BTSG Large Ownership Changes

This live feed shows all institutional transactions in real time.